Vectibix Solution
Product Images NDC 55513-954

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Vectibix (NDC 55513-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Kras Mcrc (study 20080763) (Vectibix 01)

Figure 1: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Kras Mcrc (study 20080763) (Vectibix 01)
FDA Label Image

Figure 2: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Ras Mcrc (study 20100007) (Vectibix 02)

Figure 2: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Ras Mcrc (study 20100007) (Vectibix 02)
FDA Label Image

Figure 3: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Kras Mcrc (study 20050203) (Vectibix 03)

Figure 3: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Kras Mcrc (study 20050203) (Vectibix 03)
This is not available as the text seems to be a combination of gibberish characters, symbols and unrecognizable numbers.*
FDA Label Image

Figure 4: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Ras Mcrc (study 20050203) (Vectibix 04)

Figure 4: Kaplan Meier Plot Of Overall Survival In Patients With Wild Type Ras Mcrc (study 20050203) (Vectibix 04)
FDA Label Image

Single-dose Vialndc 55513-954-01amgen®vectibix®(panitumumab)injection100 mgeach 5 mL Single-dose Vial Ofvectibix® Contains 100 mgpanitumumab In A Sterile,preservative-free Solution(ph 5.8) Containing 29 mg Sodiumchloride And 34 mg Sodium Acetatein Water For Injection, Usp.store At 2° To 8°c.do Not Freeze Or Shake.protect From Direct Sunlight.rx Only (Vectibix 06)

Single-dose Vialndc 55513-954-01amgen®vectibix®(panitumumab)injection100 mgeach 5 mL Single-dose Vial Ofvectibix® Contains 100 mgpanitumumab In A Sterile,preservative-free Solution(ph 5.8) Containing 29 mg Sodiumchloride And 34 mg Sodium Acetatein Water For Injection, Usp.store At 2° To 8°c.do Not Freeze Or Shake.protect From Direct Sunlight.rx Only (Vectibix 06)
Single-Dose Vial NDC 55513-954-01, Vectibix (panitumumab) Injection, is a sterile, preservative-free solution containing 100 mg panitumumab, 29 mg sodium chloride, and 34 mg sodium acetate in Water for Injection, USP, with a pH of 5.8. The solution is stored at 2° to 8°C and should not be frozen or shaken. It is essential to protect the vial from direct sunlight. "R Only" is also mentioned.*
FDA Label Image

Single Use Vialndc 55513-955-01amgen®vectibix®(panitumumab)200 mg200 mg/10 mLinjection For Intravenous Infusionno Preservativestore At 2° To 8°c.do Not Freeze Or Shake.protect From Direct Sunlight.discard Any Unused Portion Of The Vial.rx Only (Vectibix 07)

Single Use Vialndc 55513-955-01amgen®vectibix®(panitumumab)200 mg200 mg/10 mLinjection For Intravenous Infusionno Preservativestore At 2° To 8°c.do Not Freeze Or Shake.protect From Direct Sunlight.discard Any Unused Portion Of The Vial.rx Only (Vectibix 07)
Vectibix (panitumumab) Injection is a medication supplied in a 20 mL single-dose vial for intravenous use manufactured by Amgen. It contains 400 mg panitumumab in a sterile solution with sodium chloride and sodium acetate in Water for Injection. It is recommended to store the medication at 2° to 8°C and protect it from direct sunlight.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.